Famed investor Martin Shkreli picked a busy day to declare war on one of the market's hottest AI infrastructure names.
CoreWeave Inc.
(NASDAQ:CRWV) shares jumped after second-quarter results showed revenue surging 112% year-over-year to $2.58 billion, alongside a raised full-year 2026 revenue forecast, backed by an order backlog exceeding $104 billion.
"Pharma Bro" remains unimpressed.
"Coreweave is a short. debt is too large to generate FCF," the former hedge fund manager wrote Wednesday on X.












